Cardiogenic shock cost-effectiveness of therapy

Cardiogenic Shock Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Cardiogenic shock from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Criteria
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Cardiogenic shock cost-effectiveness of therapy On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Cardiogenic shock cost-effectiveness of therapy All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Cardiogenic shock cost-effectiveness of therapy
CDC on Cardiogenic shock cost-effectiveness of therapy
Cardiogenic shock cost-effectiveness of therapy in the news
Blogs on Cardiogenic shock cost-effectiveness of therapy
Directions to Hospitals Treating Cardiogenic shock
Risk calculators and risk factors for Cardiogenic shock cost-effectiveness of therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: João André Alves Silva, M.D. [2]

Cost-Effectiveness

Attending to the fact that cardiogenic shock is a lethal condition, with a high mortality rate, if not diagnosed early and treatment started in the shortest time-span possible, an aggressive diagnostic and therapeutic approach are of uttermost importance, therefore justifying the costs involved in the procedures.

References

Template:WikiDoc Sources